191 related articles for article (PubMed ID: 31593976)
1. Adoptive cell therapies for posttransplant infections.
Sutrave G; Gottlieb DJ
Curr Opin Oncol; 2019 Nov; 31(6):574-590. PubMed ID: 31593976
[TBL] [Abstract][Full Text] [Related]
2. Adoptive antifungal T cell immunotherapy--into the clinic?
Lehrnbecher T; Schmidt S; Koehl U; Schuster FR; Uharek L; Klingebiel T; Tramsen L
Med Mycol; 2011 Apr; 49 Suppl 1():S164-9. PubMed ID: 20586680
[TBL] [Abstract][Full Text] [Related]
3. Adoptive T Cell Therapy Strategies for Viral Infections in Patients Receiving Haematopoietic Stem Cell Transplantation.
Ottaviano G; Chiesa R; Feuchtinger T; Vickers MA; Dickinson A; Gennery AR; Veys P; Todryk S
Cells; 2019 Jan; 8(1):. PubMed ID: 30646564
[TBL] [Abstract][Full Text] [Related]
4. Cellular therapy for multiple pathogen infections after hematopoietic stem cell transplant.
Sutrave G; Blyth E; Gottlieb DJ
Cytotherapy; 2017 Nov; 19(11):1284-1301. PubMed ID: 28927824
[TBL] [Abstract][Full Text] [Related]
5. Applications of virus-specific T cell therapies post-BMT.
Motta CM; Keller MD; Bollard CM
Semin Hematol; 2023 Jan; 60(1):10-19. PubMed ID: 37080705
[TBL] [Abstract][Full Text] [Related]
6. Adoptive immunotherapy with virus-specific T cells.
Fuji S; Kapp M; Grigoleit GU; Einsele H
Best Pract Res Clin Haematol; 2011 Sep; 24(3):413-9. PubMed ID: 21925094
[TBL] [Abstract][Full Text] [Related]
7. Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation.
Ma CK; Blyth E; Clancy L; Simms R; Burgess J; Brown R; Deo S; Micklethwaite KP; Gottlieb DJ
Cytotherapy; 2015 Oct; 17(10):1406-20. PubMed ID: 26349000
[TBL] [Abstract][Full Text] [Related]
8. Harnessing T Cells to Control Infections After Allogeneic Hematopoietic Stem Cell Transplantation.
Basso S; Compagno F; Zelini P; Giorgiani G; Boghen S; Bergami E; Bagnarino J; Siciliano M; Del Fante C; Luppi M; Zecca M; Comoli P
Front Immunol; 2020; 11():567531. PubMed ID: 33178192
[TBL] [Abstract][Full Text] [Related]
9. Viral-specific adoptive immunotherapy after allo-SCT: the role of multimer-based selection strategies.
Ramírez N; Olavarría E
Bone Marrow Transplant; 2013 Oct; 48(10):1265-70. PubMed ID: 23318538
[TBL] [Abstract][Full Text] [Related]
10. The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care.
Saglio F; Hanley PJ; Bollard CM
Cytotherapy; 2014 Feb; 16(2):149-59. PubMed ID: 24438896
[TBL] [Abstract][Full Text] [Related]
11. Adoptive T Cell Immunotherapy for Patients with Primary Immunodeficiency Disorders.
McLaughlin LP; Bollard CM; Keller M
Curr Allergy Asthma Rep; 2017 Jan; 17(1):3. PubMed ID: 28116637
[TBL] [Abstract][Full Text] [Related]
12. Cellular immunotherapy for viral infection after HSC transplantation.
Moss P; Rickinson A
Nat Rev Immunol; 2005 Jan; 5(1):9-20. PubMed ID: 15630425
[TBL] [Abstract][Full Text] [Related]
13. Prospects for adoptive T-cell therapy for invasive fungal disease.
Castellano-Gonzalez G; Clancy LE; Gottlieb D
Curr Opin Infect Dis; 2017 Dec; 30(6):518-527. PubMed ID: 28984641
[TBL] [Abstract][Full Text] [Related]
14. Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea.
Cho SY; Lee HJ; Lee DG
Korean J Intern Med; 2018 Mar; 33(2):256-276. PubMed ID: 29506345
[TBL] [Abstract][Full Text] [Related]
15. Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT.
Feucht J; Opherk K; Lang P; Kayser S; Hartl L; Bethge W; Matthes-Martin S; Bader P; Albert MH; Maecker-Kolhoff B; Greil J; Einsele H; Schlegel PG; Schuster FR; Kremens B; Rossig C; Gruhn B; Handgretinger R; Feuchtinger T
Blood; 2015 Mar; 125(12):1986-94. PubMed ID: 25617426
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for opportunistic infections: Current status and future perspectives.
Fuji S; Löffler J; Einsele H; Kapp M
Virulence; 2016 Nov; 7(8):939-949. PubMed ID: 27385102
[TBL] [Abstract][Full Text] [Related]
17. Viral-specific T-cell transfer from HSCT donor for the treatment of viral infections or diseases after HSCT.
Qian C; Wang Y; Reppel L; D'aveni M; Campidelli A; Decot V; Bensoussan D
Bone Marrow Transplant; 2018 Feb; 53(2):114-122. PubMed ID: 29058697
[TBL] [Abstract][Full Text] [Related]
18. Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation.
Kaeuferle T; Krauss R; Blaeschke F; Willier S; Feuchtinger T
J Hematol Oncol; 2019 Feb; 12(1):13. PubMed ID: 30728058
[TBL] [Abstract][Full Text] [Related]
19. SOHO State of the Art Updates and Next Questions | CTLs for Infections Following Stem Cell Transplantation.
Rischall A; Olson A
Clin Lymphoma Myeloma Leuk; 2024 Jun; 24(6):340-347. PubMed ID: 38267354
[TBL] [Abstract][Full Text] [Related]
20. The role of virus-specific adoptive T-cell therapy in hematopoietic transplantation.
Sellar RS; Peggs KS
Cytotherapy; 2012 Apr; 14(4):391-400. PubMed ID: 22420834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
